Integrin antagonists as potential therapeutic options for the treatment of Crohn’s disease.
- Published in:
- Expert Opinion on Investigational Drugs, 2016, v. 25, n. 3, p. 263, doi. 10.1517/13543784.2016.1148137
- By:
- Publication type:
- Article
Works by McLean, Leon P.
Results: 7
1
2
Frequency of Surveillance and Impact of Surveillance Colonoscopies in Patients With Ulcerative Colitis Who Developed Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
3
Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis.
- Published in:
- Expert Opinion on Drug Metabolism & Toxicology, 2016, v. 12, n. 7, p. 833, doi. 10.1080/17425255.2016.1181171
- By:
- Publication type:
- Article
4
Role of Macrophages in the Altered Epithelial Function during a Type 2 Immune Response Induced by Enteric Nematode Infection.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084763
- By:
- Publication type:
- Article
5
Diabetic Ketoacidosis Associated with Aripiprazole.
- Published in:
- 2008
- By:
- Publication type:
- Case Study
6
Adverse events in IBD therapy: the 2018 update.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2018, v. 12, n. 12, p. 1183, doi. 10.1080/17474124.2018.1545574
- By:
- Publication type:
- Article
7
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.
- Published in:
- Expert Review of Gastroenterology & Hepatology, 2014, v. 8, n. 3, p. 223, doi. 10.1586/17474124.2014.881715
- By:
- Publication type:
- Article